Fig. 3From: Neutral effects of SGLT2 inhibitors in acute coronary syndromes, peripheral arterial occlusive disease, or ischemic stroke: a meta-analysis of randomized controlled trialsForest plot of effects of SGLT2i on peripheral arterial occlusive diseaseBack to article page